Viewing nowCombinationExpos 5/80 mg Tablets
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Iksu Pharmaceutical Co., Ltd.

MFDS item code 201601867 · Approved 2016.04.07 · Insurance code 658501960
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension where blood pressure is not adequately controlled with amlodipine or valsartan monotherapy.
The recommended dose of this medicine is 1 tablet once daily, taken with water with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Elderly patients aged 65 years and older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy. If pregnancy is confirmed, discontinue use immediately. Patients with allergies to the ingredients in this medication or similar medications, women who are pregnant or breastfeeding, those with severe kidney or liver dysfunction should not take this medication. Patients who are sodium or fluid depleted could experience hypotension with this medication, so their condition should be well checked before starting treatment, and if hypotensive symptoms occur, appropriate measures should be taken immediately. Patients with hyperkalemia must frequently monitor potassium levels when taking this medication with drugs that increase potassium. Patients with impaired kidney function also require caution. Patients with kidney issues, those who have undergone kidney transplants, those with a history of angioedema, patients post-heart failure or myocardial infarction, and those with aortic stenosis should use this medication with caution under close medical supervision. During treatment with this medication, side effects such as headache, dizziness, edema, itching, rash, dyspepsia, and hypotension may occur, and if symptoms are severe or abnormal, medical advice should be sought immediately. Caution is advised when driving or operating machinery as dizziness or fatigue may occur. This medication can interact with other antihypertensive drugs, diuretics, potassium-sparing agents, NSAIDs, etc., so inform your healthcare provider about any other medications you are taking. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should avoid taking this medication. Children under 18 years of age are not recommended for this medication as safety and efficacy have not been sufficiently established. Elderly patients may take similar doses as adults but should consult a physician based on their physical condition. In cases of overdose, severe hypotension, tachycardia, or shock may occur, so strict adherence to the prescribed dosage is essential, and immediate emergency treatment should be obtained if abnormal symptoms arise.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pain in the throat and larynx, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, sweating, rash, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, frequent urination, polyuria, erectile dysfunction, edema, subcutaneous edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, reduced libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, double vision, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste abnormalities, peripheral neuropathy, hypertonic myopathy, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, hives, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neural hyperexcitability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, sensory loss
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius to ensure the medication's effectiveness.
Dark yellow round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Iksu Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.